相关实验视频
Updated: Jan 9, 2026
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.5K
血清总胆固醇水平与克罗恩氏病临床严重程度之间的关联:一个回顾性横截面研究
Jinchun Ni1, Yunna Tang1, Fangyuan Zhou1,2,3
1Department of Gastroenterology, Clinical Research Center for Gut Microbiota and Digestive Diseases of Fujian Province, The National Key Clinical Specialty, School of Medicine, Zhongshan Hospital Xiamen University, Xiamen University, Xiamen, Fujian, China.
Frontiers in medicine
|December 8, 2025
概括
低总胆固醇 (TC) 可能表明更严重的克朗氏病.
科学领域:
- 胃肠病学和肝病学
- 临床生物化学 临床生物化学
- 炎症性肠道疾病研究研究
背景情况:
- 克罗恩氏病 (CD) 是一种慢性炎症性肠病.
- 了解CD临床活动的生物标志物对于患者管理至关重要.
- 血清脂质概况,包括总胆固醇 (TC),正在研究它们在CD中的作用.
研究的目的:
- 研究血清总胆固醇 (TC) 水平与克罗恩病 (CD) 的临床活性之间的关系.
- 为了识别与CD严重程度相关的潜在脂质代谢标志物.
主要方法:
- 追溯横截面研究包括104名CD患者和20名健康对照.
- 测量血清尿酸 (SUA) 和脂质代谢指标 (包括TC).
- 根据克罗恩氏病活动指数 (CDAI) 成绩,将CD患者分为轻度和中度活动组.
主要成果:
- 与对照组相比,CD患者的TC,阿波利波蛋白A1 (apo A1),阿波利波蛋白B (apo B),高密度脂蛋白胆固醇 (HDL-C) 和低密度脂蛋白胆固醇 (LDL-C) 的水平较低.
- 中度CD患者的TC和LDL-C水平低于轻度CD患者.
- 低TC (≤3.5 mmol/L) 是更严重疾病 (OR = 4.50,p = 0.004) 的独立风险因素,与C反应蛋白 (CRP) 和CDAI得分负相关.
结论:
- 血清总胆固醇 (TC) 可能作为评估克罗恩病临床疾病活性的潜在补充标志物.
- 需要进一步的纵向研究来验证TC作为CD活性生物标志物的可靠性.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
925
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
925
01:17Chronic Bowel Disorders: Introduction
734
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
734
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
617
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
617
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
862
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
862
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
536
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
536
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
507
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
507